Loss of p53 Gene Mutation after Irradiation Is Associated with Increased Aggressiveness in Recurring Head and Neck Cancer

Clinical Cancer Research

Volumn 2, Issue 9, 1996, Pages 1577-1582

  Gallo, Oreste ^a   Chiarelli, Ilaria ^a   Bianchi, Simonetta ^a   Calzolari, Anna ^a   Simonetti, Laura ^a   Porfirio, Berardino ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER INVASION; GENETICS; HEAD AND NECK TUMOR; HUMAN; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; RADIATION EXPOSURE; SINGLE STRAND CONFORMATION POLYMORPHISM; SURVIVAL; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SURVIVAL ANALYSIS;

EID: 0030222998     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Suit, H. D. Local control and patient survival. Int. J. Radiat Oncol. Biol. Phys., 23: 653-660, 1992.
2. Suit, H. D., Allam, A., Allalunis-Turner, J., Brock, W., Girinsky, T., Hill, S., Hunter, N., Milas, L., Pearcey, R., Peters, L., Welch, D. R., West, C., and Efird, J. Is tumor cell radiation resistance correlated with metastatic ability? Cancer Res., 54: 1736-1741, 1994.
3. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad Sci. USA, 89: 7492-7495, 1992.
4. Lowe, S. W., Schmitt, E. M., Smith, S W., Osborne, B A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond), 362: 847-849, 1993.
5. Clarke, A. R., Purdie, C. A, Harrison, D. J, Morris, R. G., Bird, C. C, Hooper, M. L., and Wyllie, A H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
6. Kastan, M B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage Cancer Res, 51: 6304-6311, 1991.
7. Lu, X., and Lane, D. P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell, 75: 765-768, 1993.
8. Greenblatt, M S., Bennet, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994
9. Lee, J. M., and Bernstein, A. p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA, 90, 5742-5746, 1993.
10. Lowe, S. W., Ruley H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
11. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. F., Housman, D. E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Washington DC), 266: 807-810, 1994.
12. Brachman, D. G., Hallahan, D E., Beckett, M. A., Yandell, D. W., and Weichselbaum, R R. p53 gene mutations and abnormal retinoblastoma protem in radiation-induced human sarcomas. Cancer Res, 51: 6393-6396, 1991.
13. Taylor, J. A., Watson, M. A., Devereux, T R., Michels, R. Y., Saccomanno, G., and Anderson, M. Mutational hotspots in the p53 gene in radon-associated lung tumors from uranium miners. Lancet, 343: 86-87, 1993.
14. Toguchida, J., Yamaguchi, T., Ritchie, B., Beauchamp, R. L., Dayton, S H, Herrera, G E., Yamamuro, T., Kotoura, Y., Sasaki, M. S., Little, J B., Weichselbaum, R R, Ishizaki, K., and Yandell, D W Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res., 52: 6194-6199, 1992.
15. Sakai, E., and Tsuchida, N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes Oncogene, 7, 927-933, 1992.
16. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
17. Bhatia, K., Guttierrez, M. I., Huppi, K., and Magrath, I. T. PCR detection of a neutral CGA/CGG dimorphism in exon 6 of the human p53 gene. Nucleic Acids Res., 20: 928, 1992.
18. McDaniel, T., Carbone, D., Takahashi, T., Chumakov, P., Chang, E H., Pirollo, K. F., Yin, J., Huang, Y., and Meltzer, S. J. The MspI polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products. Nucleic Acids Res., 19: 4796, 1991.
19. Futreal, P. A., Barrett, J. C., and Wiseman, R. W. An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res., 19: 6977, 1991.
20. Kaplan, E. L, and Meier, P. Non parametric estimations from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
21. Smith, C A. B. Chi-squared with small numbers. Ann. Hum. Genet., 50: 163-167, 1986.
22. Lee, J. M., Abrahamson, J. L. A., Kandel, R, Donehower, L. A., and Bernstein, A. Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene, 9, 3731-3736, 1994.
23. 1 checkpoint does not decrease cell survival following DNA damage. Cancer Res., 53: 4164-4168, 1993.
24. McIllwrath, A. J., Vasey, P. A., Ross, G. M., and Brown, R. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 radiosensitivity. Cancer Res., 54: 3718-3722, 1994.
25. Jung, M., Notario, V., and Dritschilo, A Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells. Cancer Res., 52: 6390-6393, 1992.
26. Brachman, D. G., Beckett, M., Graves, D., Haraf, D., Vokes, E., and Weichselbaum, R. R. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res., 53, 3667-3669, 1993.
27. Biard, D. S. F., Martin, M., Le Rhun, Y., Duthu, A., Lefaix, J. F., May, E., and May, P. Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res., 54: 3361-3364, 1994.
28. Brachman, D. G., Graves, D., Vokes, E., Beckett, M., Haraf, D., Montag, D., Dunphy, E., Mick, R., Yandell, D., and Weichselbaum, R. R. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res., 52: 4832-4836, 1992.
29. Maestro, R., Dolcetti, R., Gasparotto, D., Doglioni, C., Pelucchi, S., Barzan, L., Grandi, E., and Boiocchi, M. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene, 7: 1159-1156, 1992.
30. Cho, Y., Gorina, S., Jeffrey, P. D., and Pavletich, N. P. Crystal structure of a TP53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science (Washington DC), 256: 346-355, 1994.
31. Kemp, C. J., Wheldon, T., and Balmain, A p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat. Genet., 8: 66-69, 1994.
32. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., and Vogelstein, B. Clonal expansion of the p53 mutant cells is associated with brain tumor progression. Nature (Lond.), 355. 846-847, 1992.
33. Weichselbaum, R. R., Beckett, M. A., Schwartz, J. L., and Dritschilo, A Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int. J. Radiat. Biol. Phys., 15: 575-579, 1988.
34. Nowell, P The clonal evolution of tumor cell populations. Science (Washington DC), 194: 23-28, 1976.
35. Zhang, W., Funk, W. D., Wright, W. E., Shay, J. W., and Deisseroth, A. B. Novel DNA binding of p53 mutants and their role in transcriptional activation. Oncogene, 8: 2555-2559, 1993.
36. Unger, T., Mietz, J. A., Scheffner, M., Yee, C. L., and Howley, P. M. Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Mol. Cell. Biol., 13, 5186-5194, 1993.
37. 1/S boundary after irradiation. Oncogene, 12: 875-882, 1996.
38. Børresen, A. L., Andersen T. I., Eyfjörd J. E., Cornelis, R. S, Thorlacius S., Borg, Å., Johansson, U., Theillet, C., Scherneck, S., Hartman, S., Cornelisse, C J., Hovig, E., and Devilee, P TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chromosomes & Cancer, 14. 71-75, 1995.